EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antibody cross-reactivity among alphaviruses in clinical practice

Jasmin Hatami, Anja C M de Bruin, Zoltán Bánki, Félix A Rey, Gisa Gerold

Trends in Microbiology · 2026

DOI: 10.1016/j.tim.2025.07.011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Microbiology, 2026. Verfasst von Jasmin Hatami und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Alphavirus, Antibodies, Viral, Alphavirus Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alphaviruses are mosquito-borne pathogens causing rheumatological disease and encephalomyelitis. Their spread, enhanced by climate change, presents a growing global health threat. To date, no specific treatments and, except for chikungunya virus, no preventive vaccines exist. Alphavirus infection induces cross-reactive antibodies targeting conserved epitopes in glycoprotein E1 and E2. While cross-reactivity can facilitate the development of broad-spectrum vaccines, it complicates serological diagnosis in regions with multiple co-circulating alphaviruses. This review examines how antibody cross-reactivity can foster development of cross-protective vaccines and therapeutics but also how it may present challenges such as antibody-dependent enhancement of disease and diagnostic misinterpretation. Understanding the conservation of epitopes is crucial for designing effective therapies, vaccines, and precise diagnostics to mitigate the alphavirus disease burden globally.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlphavirusAntibodies, ViralAlphavirus InfectionsCross ReactionsHumansAnimalsEpitopesViral VaccinesAntibodies, NeutralizingViral Envelope Proteins

Stichwörter der Autor:innen

alphavirusesantibodiescross-reactivityserologytherapiesvaccines

Substanzen

Antibodies, ViralEpitopesViral VaccinesAntibodies, NeutralizingViral Envelope Proteins

Autor:innen und Institutionen

  • Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria.
  • Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: zoltan.banki@i-med.ac.at.
  • Institut Pasteur, Unité de Virologie Structurale, Department Virologie, Paris, France. Electronic address: felix.rey@pasteur.fr.
  • Institute of Virology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: gisa.gerold@i-med.ac.at.

Zitieren

APA

Hatami, J., de Bruin, A. C. M., Bánki, Z., Rey, F. A., & Gerold, G. (2026). Antibody cross-reactivity among alphaviruses in clinical practice. Trends in Microbiology. https://doi.org/10.1016/j.tim.2025.07.011

Vancouver

Hatami J, de Bruin ACM, Bánki Z, Rey FA, Gerold G. Antibody cross-reactivity among alphaviruses in clinical practice. Trends in Microbiology. 2026. doi:10.1016/j.tim.2025.07.011

BibTeX
@article{Hatami2026,
  author = {Hatami, Jasmin and de Bruin, Anja C M and Bánki, Zoltán and Rey, Félix A and Gerold, Gisa},
  title = {Antibody cross-reactivity among alphaviruses in clinical practice},
  journal = {Trends in Microbiology},
  year = {2026},
  doi = {10.1016/j.tim.2025.07.011}
}
Kostenlos starten →